We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.5B
AUM Growth
+$2.94B
Cap. Flow
+$1.45B
Cap. Flow %
9.35%
Top 10 Hldgs %
30.63%
Holding
2,230
New
735
Increased
384
Reduced
378
Closed
720

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$614M
2
AAPL icon
Apple
AAPL
+$443M
3
BLD
TopBuild
BLD
+$391M
4
SPCX
SpaceX
SPCX
+$329M
5
PEN icon
Penumbra
PEN
+$203M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.96B
2
NVDA icon
NVIDIA
NVDA
+$425M
3
SNDK
Sandisk
SNDK
+$88M
4
SO icon
Southern Company
SO
+$80.6M
5
PPL
PPL Corp
PPL
+$74.1M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Industrials 13.64%
3 Consumer Discretionary 9.5%
4 Healthcare 7.9%
5 Financials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGNX icon
1976
Regenxbio
RGNX
$708M
-115,444
Closed -$967K
RIGL icon
1977
Rigel Pharmaceuticals
RIGL
$857M
-10,851
Closed -$293K
RIO icon
1978
Rio Tinto
RIO
$171B
-12,588
Closed -$1.17M
RIOT icon
1979
Riot Platforms
RIOT
$7.44B
-369,635
Closed -$4.57M
RITM icon
1980
Rithm Capital
RITM
$5.69B
-476,668
Closed -$4.52M
RIVN icon
1981
Rivian
RIVN
$24.6B
-247,796
Closed -$3.73M
RNG icon
1982
RingCentral
RNG
$5.6B
-109,084
Closed -$4.06M
RNR icon
1983
RenaissanceRe
RNR
$13.4B
-13,350
Closed -$3.97M
RPRX icon
1984
Royalty Pharma
RPRX
$27.3B
-123,562
Closed -$5.93M
RRC icon
1985
Range Resources
RRC
$9.59B
-29,305
Closed -$1.32M
RRR icon
1986
Red Rock Resorts
RRR
$3.61B
-27,218
Closed -$1.45M
RSP icon
1987
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
-202,526
Closed -$38.9M
RTO icon
1988
Rentokil
RTO
$11.9B
-8,049
Closed -$253K
RUN icon
1989
Sunrun
RUN
$2.21B
-113,758
Closed -$1.54M
RUSHB icon
1990
Rush Enterprises Class B
RUSHB
$8.58B
-25
Closed -$1.61K
RUSHA icon
1991
Rush Enterprises Class A
RUSHA
$8.54B
-46,403
Closed -$3.07M
RVMD icon
1992
CALL
Revolution Medicines
RVMD
$44.9B
-17,500
Closed -$1.7M
RVLV icon
1993
Revolve Group
RVLV
$1.69B
-145,909
Closed -$3.3M
RXST icon
1994
RxSight
RXST
$260M
-106,638
Closed -$657K
RYN icon
1995
Rayonier
RYN
$6.31B
-64,087
Closed -$1.32M
RZLT icon
1996
Rezolute
RZLT
$490M
-88,226
Closed -$269K
S icon
1997
CALL
SentinelOne
S
$7.26B
-7,000
Closed -$90.2K
SABS icon
1998
SAB Biotherapeutics
SABS
$344M
-768,627
Closed -$2.94M
SANA icon
1999
Sana Biotechnology
SANA
$1.17B
-61,659
Closed -$178K
SBH icon
2000
Sally Beauty Holdings
SBH
$1.55B
-42,846
Closed -$593K

Similar funds

Michael Gelband's Q2 2026 Portfolio in Review

As of Q2 2026, Michael Gelband held 2,230 positions worth $15.5B, up 23% from $12.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael Gelband deployed $1.45B of net new capital in Q2 2026, opening 735 new positions and adding to 384 existing holdings. Its largest new stake was SpaceX: 1,938,935 shares worth $331M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $1.96B trimmed.

  • Michael Gelband's largest Q2 2026 buy was SpaceX: 1,938,935 shares worth $331M.
  • Michael Gelband added most to Amazon in Q2 2026, an estimated $614M increase.
  • Michael Gelband's biggest Q2 2026 reduction was Tesla, cutting an estimated $1.96B.
  • Michael Gelband fully exited Southern Company in Q2 2026, selling an estimated $80.6M.
  • Michael Gelband's ten largest holdings make up 31% of its $15.5B portfolio in Q2 2026.
  • Michael Gelband opened 735 new positions and closed 720 in Q2 2026.
  • Michael Gelband's portfolio value rose 23% quarter-over-quarter to $15.5B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.